Here, too, I remain invested.
Fourth quarter GAAP earnings per share of $1.70 beat expectations by $0.29 .
Sales of USD 107.1 million (+17.6% compared to the previous year) exceeded expectations by USD 1.97 million .
8Lun·
Krystal Biotech exceeds sales and earnings forecasts; publishes outlook for the 2026 financial year
12